John Blair
Pediatrics · Louisville, KYNPI 1982668752
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 159 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 14.5% — the pattern of someone who eats at a lot of different presentations. Among pediatrics clinicians in KY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 159 payments — averaging $16.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ironshore Pharmaceuticals Inc.$383
- Tris Pharma Inc$322
- Pfizer$206
- Neos Therapeutics, LP$194
- Seqirus USA Inc$186
- GSK$184
- plus $1K from 15 others
Across 168 payments — averaging $5768.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$693K
- Novavax Inc$158K
- GSK$105K
- Sanofi Pasteur Inc.$14K
What the payments were for
- Consulting fees$251%
- Food & beverage$2,61099%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ironshore Pharmaceuticals Inc. | 25 | $383 |
| Tris Pharma Inc | 21 | $322 |
| Pfizer | 12 | $206 |
| Neos Therapeutics, LP | 14 | $194 |
| Seqirus USA Inc | 5 | $186 |
| GSK | 13 | $184 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $179 |
| Merck | 10 | $170 |
| Sanofi Pasteur Inc. | 10 | $154 |
| Supernus Pharmaceuticals, Inc. | 6 | $148 |
| Corium, LLC | 9 | $136 |
| Collegium Pharmaceutical, Inc. | 5 | $111 |
| Cranial Technologies, Inc | 4 | $70 |
| Genentech USA, Inc. | 3 | $46 |
| Shire North American Group Inc | 2 | $28 |
| Rhodes Pharmaceuticals L.p. | 2 | $27 |
| Dermira, Inc. | 2 | $24 |
| Verrica Pharmaceuticals Inc. | 1 | $19 |
| AstraZeneca | 1 | $18 |
| Alfasigma USA, Inc. | 1 | $15 |
| LNHC, Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Flucelvax$103
How this compares
$2,635 in reported general payments places this provider in the 90th percentile of 777 pediatrics providers in Kentucky.
Other pediatrics in Louisville
- Christian BerkhahnLouisville$85K
- Maurice AllgeierLouisville$38K
- Patricia PurcellLouisville$27K
- Amber PendletonLouisville$10K
- Jeetendra SahLouisville$7K
- Klint SchwenkLouisville$6K
- Heather RushLouisville$5K
- Julia RichersonLouisville$4K
- Wendy DalyLouisville$4K
- Nicholas HinkebeinLouisville$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.